Why is Senores Pharma. falling/rising?

As of 13-Aug, Senores Pharmaceuticals Ltd is experiencing a price increase, currently at 680.80, reflecting a rise of 13.3 points or 1.99%. The stock has shown strong performance recently, with a consecutive gain over the last three days, resulting in a total increase of 4.49%. It opened with a gain of 3.03% today and reached an intraday high of Rs 687.75. Additionally, the stock has outperformed its sector by 0.5% today and has demonstrated impressive returns over various periods, including a 19.67% increase year-to-date and an 11.69% rise over the past month. The company benefits from a low debt-to-equity ratio and strong long-term growth, with net sales and operating profit showing significant annual increases. However, there are concerns regarding its valuation, as indicated by a high price-to-book ratio and a relatively low return on equity.
In the broader market context, Senores Pharmaceuticals has outperformed the Sensex, which has seen a slight decline of 0.01% over the past week, while the stock itself has gained 5.42%. This trend of outperformance is notable, especially given the benchmark's negative return of 2.38% over the past month. Despite the positive price movement, there are signs of falling participation from institutional investors, who have reduced their stake by 0.65% in the last quarter, which could indicate a cautious outlook among more sophisticated market participants.